Table 1.
Baseline Patient Characteristics
| Characteristic | Mean±SD or Median [IQR] | Number (%) |
|---|---|---|
| Age, y | 57.7±6.8 | |
| Sex, n (%) male | 12 (80) | |
| Weight, lb | 211±38 | |
| Body mass index, kg/m2 | 30.8±6.6 | |
| Race, n (%) | ||
| White | 9 (60) | |
| Black | 6 (40) | |
| Systolic blood pressure, mm Hg | 103.7±11.6 | |
| Diastolic blood pressure, mm Hg | 66.5±8.4 | |
| Heart rate, beats/min | 64.1±8.7 | |
| Respiratory rate, breaths/min | 17.5±3.8 | |
| Left ventricular ejection fraction, % | 28.1±8.2 | |
| Left ventricular diastolic dysfunction, E/E′ | 12.2 [6.7, 17.2] | |
| NYHA functional class, n (%) NYHA II | 14 (93.3) | |
| Concomitant medications, n (%) | ||
| ACE inhibitor/ARB | 12 (80) | |
| β‐Blocker | 15 (100) | |
| Aldosterone antagonist | 9 (60) | |
| Digoxin | 4 (27) | |
| Diuretic | 13 (87) | |
| Dose (mg of furosemide or equivalent) | 40 [20, 40] | |
| NT‐proBNP, pg/mL | 1508 [216 to 1709] | |
| eGFR, mL/min per 1.73 m2 | 68 [62 to 75] | |
| Dyspnea score, Likert 5‐point | 1 [1, 1] | |
| 6MWT, feet | 1120 [1027, 1280] | |
Data are presented as n (%), mean±SD or median [interquartile range, IQR]. 6MWT indicates 6‐minute walk test; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; NYHA, New York Heart Association.